Your browser doesn't support javascript.
loading
Nutrition and lifestyle intervention in type 2 diabetes: pilot study in the Netherlands showing improved glucose control and reduction in glucose lowering medication.
Pot, Gerda K; Battjes-Fries, Marieke Ce; Patijn, Olga N; Pijl, Hanno; Witkamp, Renger F; de Visser, Marianne; van der Zijl, Nynke; de Vries, Maaike; Voshol, Peter J.
Afiliação
  • Pot GK; Department of Nutrition and Health, Louis Bolk Instituut, Bunnik, The Netherlands.
  • Battjes-Fries MC; King's College London, Division of Diabetes and Nutritional Sciences, London, UK.
  • Patijn ON; Department of Nutrition and Health, Louis Bolk Instituut, Bunnik, The Netherlands.
  • Pijl H; Department of Nutrition and Health, Louis Bolk Instituut, Bunnik, The Netherlands.
  • Witkamp RF; Division of Internal Medicine, Leids Universitair Medisch Centrum, Leiden, The Netherlands.
  • de Visser M; Division of Human Nutrition and Health, Wageningen Universiteit, Wageningen, The Netherlands.
  • van der Zijl N; Department of Neurology, AMC, Amsterdam, The Netherlands.
  • de Vries M; General Practitioner, Medical Centre te Cleeff, Haarlem, The Netherlands.
  • Voshol PJ; Springh, Den Haag, The Netherlands.
BMJ Nutr Prev Health ; 2(1): 43-50, 2019.
Article em En | MEDLINE | ID: mdl-33235957
ABSTRACT

INTRODUCTION:

Prevalence of type 2 diabetes (T2D) is increasing rapidly and lifestyle interventions to reverse diabetes are seen as a possible solution to stop this trend. New practice-based evidence is needed to gain more insight in the actual, and above all scientific, basis for these claims.

METHODS:

This observational study with a pretest post-test design aimed to pilot a 6-month multicomponent outpatient group-based nutrition and lifestyle intervention programme on glycaemic control and use of glucose lowering medication in motivated T2D patients with a body mass index (BMI) >25 kg/m2 in the Netherlands (February 2015-March 2016).

RESULTS:

74 T2D patients (56% female) aged 57.4±8.0 years with mean BMI 31.2±4.2 kg/m2 and mean waist circumference 105.4±10.2 cm were included in the study. Compared with baseline, mean HbA1c levels at 6 months were 5 mmol/mol lower (SD=10, p<0.001) and the number of participants with HbA1c levels ≤53 mmol/mol after intervention had increased (from 36% (n=26/72) to 60% (n=43/72)). At baseline, 90% of participants were taking at least one type of glucose lowering medication. At 6 months, 49% (n=35/72) of the participants had reduced their medication or eliminated it completely (13%). Secondary outcomes were significantly lower fasting glucose levels (- 1.2±2.6 mmol/L), body weight (-4.9±5.1 kg), BMI (-1.70±1.69 kg/m2) and waist circumference (-9.4±5.0 cm). Plasma lipids remained unchanged except for a decrease in triglyceride levels. Furthermore, self-reported quality of life was significantly higher while experienced fatigue and sleep problems were significantly lower.

CONCLUSION:

This pilot study showed that a 6-month multicomponent group-based program in a routine care setting could improve glycaemic control and reduce the use of glucose lowering medication in motivated T2D diabetics. A fully scaled study is needed to confirm these results.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: BMJ Nutr Prev Health Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: BMJ Nutr Prev Health Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda